•22,071 male physicians
•
•50% never smokers, 11% current smokers
•
•2x2 factorial design
•
•Beta-carotene 50 mg on alt. days (BASF, reduced
bioavailability)
and Aspirin
•
•No effect on lung cancer or mortality
•
•Relatively high baseline beta-carotene levels than in
other trials